Cargando…
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study
Background: This study aimed to develop a predictive model based on the risk of locoregional recurrence (LRR) in epidermal growth factor receptor (EGFR)-mutant stage III-pN2 lung adenocarcinoma after complete resection. Methods: A total of 11,020 patients with lung surgery were screened to determine...
Autores principales: | Li, Qi-Wen, Qiu, Bo, Liang, Wen-Hua, Wang, Jun-Ye, Hu, Wan-Ming, Zhang, Tian, Xu, Shuang-Bing, López, José, Chen, Nai-Bin, Guo, Min-Zhang, Zhao, Yi, Chen, Ling-Juan, Liu, Song-Ran, Yun, Jing-Ping, Guo, Jin-Yu, Wang, Si-Yu, Wang, Xin, Zhang, Li, Yue, Dong-Sheng, Liao, Zhong-Xing, Lin, Steven H., Long, Hao, Pang, Qing-Song, Liu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477429/ https://www.ncbi.nlm.nih.gov/pubmed/32922551 http://dx.doi.org/10.7150/jca.47119 |
Ejemplares similares
-
Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma
por: Li, Qiwen, et al.
Publicado: (2021) -
Anti‐epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: Peng, Hao, et al.
Publicado: (2018) -
Molecular risk factors for locoregional recurrence in resected non‐small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2023) -
Phosphate transporters, PnPht1;1 and PnPht1;2 from Panax notoginseng enhance phosphate and arsenate acquisition
por: Cao, Guan-Hua, et al.
Publicado: (2020) -
Potential surrogate endpoints for overall survival in locoregionally advanced nasopharyngeal carcinoma: an analysis of a phase III randomized trial
por: Chen, Yu-Pei, et al.
Publicado: (2015)